News Phathom Pharmaceuticals, Inc.

Equities

PHAT

US71722W1071

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-15 pm EDT			5-day change	1st Jan Change
10.02 ^USD	-1.18%		-9.81%	+9.75%

Mar. 07	Transcript : Phathom Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 07, 2024
Mar. 07	Phathom Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Phathom Pharmaceuticals : Corporate Overview – April 2024	Apr. 12	PU
Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference	Apr. 03	GL
Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference	Apr. 03	AQ
Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, 'VOQUEZNA Can Kick Some Acid'	Mar. 27	AQ
Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”	Mar. 26	GL
Transcript : Phathom Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 07, 2024	Mar. 07
Phathom Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 07	CI
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	Mar. 07	GL
Phathom Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024	Feb. 29	GL
Phathom Pharmaceuticals Announces VOQUEZNA Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients	Feb. 14	AQ
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients	Feb. 13	GL
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients	Feb. 13	AQ
Phathom Pharmaceuticals Announces Voquezna® Tablets for Erosive Gerd and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients	Feb. 13	CI
Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	Jan. 31	GL
Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	Jan. 31	AQ
Needham Raises Price Target on Phathom Pharmaceuticals to $26 From $23, Maintains Buy Rating	Jan. 05	MT
Phathom Pharmaceuticals, Inc.(NasdaqGS:PHAT) dropped from S&P Pharmaceuticals Select Industry Index	Dec. 18	CI
Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital	Dec. 14	GL
Phathom Pharmaceuticals Announces FDA Acceptance for Filing of VOQUEZNA Tablets New Drug Application for the Treatment of Heartburn Associated with Non-Erosive GERD	Dec. 07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Phathom Pharmaceuticals, Inc.

Equities

PHAT

US71722W1071

Summary

Filters